AI assistant
Anterix Inc. — Director's Dealing 2022
Jun 17, 2022
33018_dirs_2022-06-16_803d0c8b-e864-4784-a8f9-71a801f072b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2022-06-15
Reporting Person: OBRIEN MORGAN E (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-15 | Common Stock | M | 25000 | $25.00 | Acquired | 59313 | Direct |
| 2022-06-15 | Common Stock | S | 25000 | $40.031 | Disposed | 34313 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-15 | Stock Option (Right to Buy) | $25.00 | M | 25000 | Disposed | 2025-01-29 | Common Stock (25000) | Direct |
Footnotes
F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $40.00 to $40.595. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: The option shares are fully vested.